Printer Friendly

MENTOR RESPONDS TO REQUEST FOR IMPLANT MORATORUIUM

 MENTOR RESPONDS TO REQUEST FOR IMPLANT MORATORUIUM
 SANTA BARBARA, Calif., Jan. 6 /PRNewswire/ -- Mentor Corp.


(NASDAQ: MNTR) announced today that in a press conference held today, Food and Drug Administration Commissioner David Kessler requested a voluntary moratorium on the use of silicone-gel breast implants until new safety data can be reviewed by an FDA advisory panel. In response to the FDA press conference, Christopher J. Conway, chairman of Mentor Corp., stated: "We are perplexed and confused at this action of the FDA. The only new safety data relating to Mentor's products that we are aware of supports the safety of our products, as does all the scientific data we know of. If the FDA has data which it has not shared with the manufacturers and the public, we request that such data be made available to the public immediately, in order that other responsible scientists may evaluate it.
 "We intend to comply temporarily with the FDA's request for a moratorium while we await clarification of the basis for the request and evaluate whatever new data the FDA makes available regarding Mentor products.
 "Meanwhile, as the leading producer of saline-filled implants, which are not affected by the moratorium, we will continue to try to meet the public's need for breast implants."
 U.S. sales of silicone-gel breast implants accounted for about $11 million, or 15 percent, of Mentor's sales last year.
 Mentor Corp. produces medical and surgical devices for the specialties of urology, plastic surgery and ophthalmology.
 -0- 1/6/92
 /CONTACT: Christopher J. Conway, chairman of Mentor, 805-681-6000/
 (MNTR) CO: Mentor Corp. ST: California IN: MTC SU:


KJ-EH -- LA026 -- 7046 01/06/92 16:39 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 6, 1992
Words:276
Previous Article:SPIEGEL TO CLOSE ITS 17 HONEYBEE STORES
Next Article:AIRSHIP SHAMU TAKES MARINE ANIMAL RESEARCH TO GREAT HEIGHTS
Topics:


Related Articles
FDA PANEL DECISION ON MENTOR BREAST IMPLANTS
MENTOR CORPORATION APPLAUDS F.D.A. PANEL DECISION ON BREAST IMPLANTS
DOW CORNING WELCOMES FDA REVIEW OF ADDITIONAL INFORMATION CONCERNING SILICONE BREAST IMPLANTS
MENTOR CORP. OFFERS SALINE-FILLED BREAST IMPLANTS AS ALTERNATIVE TO SILICONE
MENTOR CORP. OFFERS SALINE-FILLED BREAST IMPLANTS AS ALTERNATIVE TO SILICONE
COURT GIVES PRELIMINARY APPROVAL TO PROPOSED MENTOR BREAST IMPLANT SETTLEMENT
COURT APPROVES MENTOR BREAST IMPLANT SETTLEMENT
MENTOR MAY CONTINUE SILICONE GEL BREAST IMPLANTS
Mentor Reports Record Third Quarter Sales.
FDA Advisory Panel Recommends Approval, With Conditions, of Mentor Silicone Gel-Filled Breast Implants; Patient Advocates Hail Decision as Victory...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters